Ret Proto-Oncogene Antikörper
Kurzübersicht für Ret Proto-Oncogene Antikörper (ABIN1450227)
Target
Alle Ret Proto-Oncogene (RET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- The RET proto-oncogeneis a receptor tyrosine kinase for members of the glial cell line-derivedneurotrophic factor family of extracellular signalling molecules
-
Produktmerkmale
- Mono- and polyclonal antibodies to human growth factors and neural growth factor receptors.
-
Aufreinigung
- RET affinity purified
-
Isotyp
- IgY
-
-
-
-
Applikationshinweise
- Westernimmunoblotting, recommended dilution 1:5 000 to 1:10 000, ELISA: 1:80 000 to 1:120000, IF 1:250 to 1:500. Polyclonal antibody working titer has to be established practically for each particularantigen and assay format
-
Kommentare
-
Synonym: Proto-oncogene tyrosine-protein kinase receptorRet, Cadherin family member 12, Proto-oncogene c-Ret
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/ml
-
Buffer
- Concentrated ammonium sulphate in PBS pH 7.4
-
Handhabung
- As product is (NH4)2SO4 precipitate, mix well by pipetting or vortexing prior use
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- This product is shipped in non-frozen liquid form in ambient conditions
-
-
- Ret Proto-Oncogene (RET)
-
Andere Bezeichnung
- RET
-
Hintergrund
- Recombinant His-tagged extracellular fragment of humanRET protein produced using CHO-based cell line. The extracellular fragment of hRET was expressed andsecreted to the cell culture supernatant. Protein was purified by Ni-affinitychromatography following gel-filtration from cell culture supernatant
-
UniProt
- P07949
-
Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-